J&J data presents ‘limited downside’ to CG Oncology, says Goldman Sachs
PremiumThe FlyJ&J data presents ‘limited downside’ to CG Oncology, says Goldman Sachs
2M ago
CG Oncology initiated with a Buy at Roth MKM
Premium
The Fly
CG Oncology initiated with a Buy at Roth MKM
2M ago
CG Oncology reports Q2 EPS (28c), consensus (37c)
Premium
The Fly
CG Oncology reports Q2 EPS (28c), consensus (37c)
3M ago
CG Oncology upgraded to Buy from Neutral at Goldman Sachs
PremiumThe FlyCG Oncology upgraded to Buy from Neutral at Goldman Sachs
6M ago
CG Oncology expects cash runway through 2027
Premium
The Fly
CG Oncology expects cash runway through 2027
6M ago
CG Oncology reports Q1 EPS (36c) vs. ($3.22) last year
Premium
The Fly
CG Oncology reports Q1 EPS (36c) vs. ($3.22) last year
6M ago
3 Best Stocks to Buy Now, 5/6/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 5/6/2024, According to Top Analysts 
6M ago
Five new option listings and one option delisting on March 12th
Premium
The Fly
Five new option listings and one option delisting on March 12th
8M ago
CG Oncology announces first patient dosed in PIVOT-006 Phase 3 trial
Premium
The Fly
CG Oncology announces first patient dosed in PIVOT-006 Phase 3 trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100